Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Greuter

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Digestive Diseases (Basel, Switzerland)|May 26, 2023
Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Roger Scherer, Philipp Schreiner, Jean-Benoit Rossel, et al.
International Archives of Allergy and Immunology|December 23, 2019
Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis TherapiesEkaterina Safroneeva, David Hafner, Claudia E Kuehni, et al.
The American Journal of Gastroenterology|March 31, 2025
Loss of Response to Off-Label Swallowed Topical Corticosteroids in Eosinophilic Esophagitis Can be Overcome by a Switch to an Esophageal-Targeted Budesonide FormulationFritz R Murray, Jean-Benoit Rossel, Ekaterina Safroneeva, et al.
United European Gastroenterology Journal|August 25, 2021
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patientsRené Roth, Stephan Vavricka, Michael Scharl, et al.
The American Journal of Gastroenterology|October 19, 2018
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort StudySylvie Scharl, Christiane Barthel, Jean-Benoit Rossel, et al.
Digestion|August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based ConsensusThomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|April 5, 2018
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort StudyLevente Parragi, N Fournier, Jonas Zeitz, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2018
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomesEkaterina Safroneeva, Lukas Balsiger, David Hafner, et al.
Plos One|April 26, 2019
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort studyLorenz Bon, Sylvie Scharl, Stephan Vavricka, et al.
Journal of Crohn'S & Colitis|August 31, 2018
Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease CourseThomas Greuter, Alberto Piller, Nicolas Fournier, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Digestive Diseases (Basel, Switzerland)|May 26, 2023
Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Roger Scherer, Philipp Schreiner, Jean-Benoit Rossel, et al.
International Archives of Allergy and Immunology|December 23, 2019
Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis TherapiesEkaterina Safroneeva, David Hafner, Claudia E Kuehni, et al.
The American Journal of Gastroenterology|March 31, 2025
Loss of Response to Off-Label Swallowed Topical Corticosteroids in Eosinophilic Esophagitis Can be Overcome by a Switch to an Esophageal-Targeted Budesonide FormulationFritz R Murray, Jean-Benoit Rossel, Ekaterina Safroneeva, et al.
United European Gastroenterology Journal|August 25, 2021
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patientsRené Roth, Stephan Vavricka, Michael Scharl, et al.
The American Journal of Gastroenterology|October 19, 2018
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort StudySylvie Scharl, Christiane Barthel, Jean-Benoit Rossel, et al.
Digestion|August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based ConsensusThomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|April 5, 2018
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort StudyLevente Parragi, N Fournier, Jonas Zeitz, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2018
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomesEkaterina Safroneeva, Lukas Balsiger, David Hafner, et al.
Plos One|April 26, 2019
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort studyLorenz Bon, Sylvie Scharl, Stephan Vavricka, et al.
Journal of Crohn'S & Colitis|August 31, 2018
Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease CourseThomas Greuter, Alberto Piller, Nicolas Fournier, et al.
Pageof 14